HIV TB coinfection - perspectives from India
- Resource Type
- Authors
- Bharat Bhushan Rewari; Anoop Kumar Puri; Amitabh Kumar; Partha Pratim Mandal
- Source
- Expert review of respiratory medicine. 15(7)
- Subject
- Pulmonary and Respiratory Medicine
medicine.medical_specialty
Tuberculosis
Policy making
Service delivery framework
Human immunodeficiency virus (HIV)
India
HIV Infections
medicine.disease_cause
03 medical and health sciences
0302 clinical medicine
Health care
medicine
Immunology and Allergy
Humans
Mass Screening
030212 general & internal medicine
Risk factor
business.industry
Coinfection
Public Health, Environmental and Occupational Health
medicine.disease
Preventive therapy
030228 respiratory system
Family medicine
business
- Language
- ISSN
- 1747-6356
Introduction: HIV and tuberculosis (TB) are two of the most challenging infections faced by humanity and place immense burden on health care systems worldwide. Both HIV and TB impact one another's progression.Areas covered: HIV is the most important risk factor for progression of latent TB to active disease. TB is the most common cause of death among People Living with HIV (PLHIV). Timely detection of TB among PLHIV and screening for HIV among TB patients, early initiation of ART and ATT among coinfected persons, provision of CPT and TB Preventive therapy along with control of air-borne infection are some of the key activities to reduce morbidity and mortality among coinfected persons. Despite many challenges, the collaboration between two programs has yielded good results and globally more than 7.3 million lives of PLHIV have been saved globally through scale-up of collaborative TB/HIV activities since 2005. The review looked into key features of both programs that are the collaboration strategies and challenges that still need to be addressed.Expert opinion: The overarching principle for effective implementation of collaborative activities is integration of the TB and HIV national programs right from policy making to service delivery and monitoring.